Literature DB >> 1338317

Benefit:risk consideration in long-term therapy with dexfenfluramine.

P Turner1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1338317

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


× No keyword cloud information.
  1 in total

Review 1.  A risk-benefit assessment of anti-obesity drugs.

Authors:  J Kolanowski
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.